Improving Aggregation Control of Recombinant Adeno‐Associated Virus Serotype 2 (rAAV2) With Small Sugars and Ionic Salts
Biotechnology Journal · 2025-11 · 20 (11)
DOI: 10.1002/biot.70157 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, online erschienen am 14.11.2025. Verfasst von Alexander Burns und 1 weiteren Autor:innen. Beteiligte Einrichtung: Amgen Bioprocessing Center, Henry E. Riggs School of Applied Life Sciences, Keck Graduate Institute, Claremont, California, USA. Hauptthemen laut MEDLINE: Dependovirus, Sugars. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Two persistent challenges in adeno‐associated virus (AAV) manufacturing are AAV particle aggregation and the separation of full and empty AAV capsids in ion‐exchange (IEX) chromatography processes, which add to AAV purification, formulation, and quality control challenges. AAV empty capsids and AAV aggregates are both considered product‐related impurities by regulatory agencies. AAV full capsids, which contain the genetic payload, is the AAV species that has the therapeutic value. Thus, it is necessary to continuously improve the control of AAV aggregation and the ratio of full to empty capsids during AAV downstream bioprocessing. We investigated a novel approach that significantly improves aggregation control of AAV serotype 2 (AAV2). The novel approach consisted of a systematic study, involving Design of Experiment (DoE), using common formulation excipients (namely, small sugars and ionic salts) to understand the effect of critical process parameters (excipient type, excipient concentration, and pH) on a critical quality attribute (AAV aggregates). With this approach, we observed a statistically significant reduction in AAV2 particle aggregation in solution. Results suggest that this aggregation‐control approach could provide insight into potentially being able to create a new strategy for improving the separation of full and empty AAV2 capsids in anion exchange (AEX) chromatography.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Amgen Bioprocessing Center, Henry E. Riggs School of Applied Life Sciences, Keck Graduate Institute, Claremont, California, USA.
Zitieren
APA
Burns, A., & Datta, S. (2025). Improving Aggregation Control of Recombinant Adeno‐Associated Virus Serotype 2 (rAAV2) With Small Sugars and Ionic Salts. Biotechnology Journal, 20(11). https://doi.org/10.1002/biot.70157
Vancouver
Burns A, Datta S. Improving Aggregation Control of Recombinant Adeno‐Associated Virus Serotype 2 (rAAV2) With Small Sugars and Ionic Salts. Biotechnology Journal. 2025;20(11). doi:10.1002/biot.70157
BibTeX
@article{Burns2025,
author = {Burns, Alexander and Datta, Saurav},
title = {Improving Aggregation Control of Recombinant Adeno‐Associated Virus Serotype 2 (rAAV2) With Small Sugars and Ionic Salts},
journal = {Biotechnology Journal},
year = {2025},
volume = {20},
number = {11},
doi = {10.1002/biot.70157}
}
EUVIMED